heart attack
By Dawn Kawamoto, The Motley Fool
| 3:15PM 2/07/2012
Every investor should be asking their portfolio companies what succession plans they have to replace their CEOs in the event of a tragedy like that which befell Micron Technology CEO Steve Appleton last week. Because unfortunately, many companies don't have any plan at all.
| 3:05PM 12/07/2011
Money woes don't just make it harder to pay for prescriptions and doctors' visits -- they can also make you more susceptible to a host of health problems. Dr. Travis Stork of 'The Doctors' offers some tips for how to save money while still taking care of yourself.
| 2:45AM 1/20/2011
When Merck halted a late-stage study of its potential clot-preventing drug vorapaxar in stroke victims last week, it didn't explain why. Now, the company has confirmed it stopped the study after concerns that the drug increased the risk of bleeding in some patients.
| 4:50PM 10/08/2010
Abbott Laboratories agreed to withdraw diet drug Meridia, after clinical trial data concluded that the drug increased the risk of heart attack and stroke and did little to help people lose weight. The Food and Drug Administration announced the recall of Meridia, which has become a highly-popular...
| 4:14PM 10/08/2010
Drug and medical-device maker Abbott Laboratories announced Friday that it will voluntarily withdraw its controversial obesity drug Meridia, (sibutramine) from the U.S. market at the request of the FDA, due to concerns it increases the risk of heart attacks and strokes.
| 7:34PM 9/22/2010
U.S. hospitals are doing a more effective job treating patients for heart attacks, pneumonia and surgical procedures, an independent healthcare accreditation organization said in a report released today.
| 1:15AM 9/02/2010
The New England Journal of Medicine called Meridia "another flawed diet pill" -- two weeks before government advisers are scheduled to review the drug -- after a study finds it raises the risk of heart attack and stroke in users with heart problems.
| 6:00AM 8/02/2010
Using calcium supplements and not vitamin D at the same time may increase the risk of myocardial infarction, or heart attacks, according to a new review of past research.
Osteoporosis patients who received the calcium supplements were about 30 percent more likely to have a heart attack than those...
| 5:50AM 8/02/2010
Here's news from the business world and other money matters to watch out for Monday (last updated 7:56 a.m. ET):
Greenspan: Recovery 'On Pause': Former Federal Reserve Chairman Alan Greenspan said over the weekend that the U.S. economy is taking a breather of sorts. "We're in a pause in a...
| 5:05PM 7/13/2010
GlaxoSmithKline, whose diabetes drug Avandia is undergoing a safety review by the FDA, has agreed to pay about $460 million to resolve about 10,000 lawsuits from users of the drug, which can allegedly cause heart attacks and strokes.